A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.
Age from 18 to 65 years old
Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48 hours of onset
Consent of the subjects, who sign the informed consent form
Women who are pregnant or breastfeeding
Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation, purulent cholangitis, etc.
Patients with a history of severe heart, liver, kidney and other important organ diseases
Patients with mental illness and malignant tumors
Parallel
Dachaihu decoction compound
Combination productDachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.
Rhubarb single medicine
DrugRhubarb single medicine
Regular therapies
Combination productRegular therapies, such as fluid therapy, for acute pancreatitis
Significant and effective rate
Significant and effective rate after 7 days of treatment
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
